How do racial disparities affect the living kidney donor evaluation process, and what could contribute to this?
What new tools are available to evaluate the risk of end-stage renal disease (ESRD) for living kidney donors, and how can these tools facilitate the donor evaluation process?
How do differences in transplant center practices impact their number of living kidney donor transplants?
What is the role of genetic testing in the living kidney donor evaluation process
What steps can be taken within the transplant community to better support living kidney donors and emphasize the need for living kidney donor follow-up
Speaker
Michael Goldstein, MD Director, Division of Organ Transplantation
Hackensack University Medical Center